Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ABH HealthcareNSE:ABH -16.56%15 ROE % is 68.90% as of Mar. 2025, which is 77% above its 10-year median of 38.89. GuruFocus rates NSE:ABH with a GF Score™ of 15/100. The stock has 2 warning signs investors should review. Among 637 Healthcare Providers & Services companies, ABH Healthcare ranks better than 94.82% on this metric.
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is four times the quarterly (Mar. 2025) net income data. The Revenue data used here is four times the quarterly (Mar. 2025) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
ABH Healthcare ROE % Related Terms
ABH Healthcare ROE % Historical Data
* Premium members only.
The historical data trend for ABH Healthcare's ROE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ABH Healthcare ROE % Chart
ABH Healthcare Annual Data
Trend
Mar22
Mar23
Mar24
Mar25
ROE %
45.95
29.18
38.26
56.88
ABH Healthcare Quarterly Data
Mar25
ROE %
68.90
NSE:ABH vs : ROE % Comparison
For the Medical Care Facilities subindustry, ABH Healthcare's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ABH Healthcare ROE % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, ABH Healthcare's ROE % distribution charts can be found below:
* The bar in red indicates where ABH Healthcare's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2025) net income data.
ROE % is displayed in the 30-year financial page.
* Note that if the average Total Stockholders Equity is zero or negative, then ROE % would be considered meaningless and hence not be calculated.
ABH Healthcare (NSE:ABH) has a ROE % of 68.90% as of Mar. 2025. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on ABH Healthcare and its competitors. This is 77% above median its historical median of 38.89. Over the past decade, ABH Healthcare's ROE % has ranged from 29.18 to 59.17. According to the industry distribution chart, ABH Healthcare ranks #33 out of 637 companies in the Healthcare Providers & Services industry, placing it in the top 5.2%.
Is ABH Healthcare's ROE % too high?
ABH Healthcare's current ROE % of 68.90% is 77% above median its 10-year median of 38.89. Over the past 10 years, this metric has ranged from a low of 29.18 to a high of 59.17. The Healthcare Providers & Services industry median ROE % is 5.87. ABH Healthcare's value of 68.90% is 1073.8% above this industry median. Based on the distribution chart, ABH Healthcare ranks #33 out of 637 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, ABH Healthcare has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does ABH Healthcare's ROE % compare to ?
According to the Healthcare Providers & Services industry distribution chart, ABH Healthcare ranks #33 out of 637 companies for ROE %. This places ABH Healthcare in the top 5% of its industry — outperforming the majority of peers. The industry median ROE % is 5.87. ABH Healthcare's value of 68.90% is 1073.8% above this benchmark. Historically, ABH Healthcare's own ROE % has ranged from 29.18 to 59.17 over the past decade. While the company's 10-year median is 38.89 vs. the industry median of 5.87, ABH Healthcare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Healthcare Providers & Services company?
The median ROE % among Healthcare Providers & Services companies is 5.87, based on 637 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. ABH Healthcare's current ROE % of 68.90% is 1073.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on ABH Healthcare and its competitors. For the Healthcare Providers & Services industry, the median ROE % is 5.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ABH Healthcare's current ROE % is 68.90%, which is 77% above median its own 10-year median of 38.89. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ABH Healthcare stock overvalued right now?
ABH Healthcare (NSE:ABH) has a current ROE % of 68.90%. The current ROE % is 68.90%, which is 77% above median its 10-year median of 38.89 and 1073.8% above the Healthcare Providers & Services industry median of 5.87. ABH Healthcare's overall GF Score™ is 15/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For ABH Healthcare (NSE:ABH), the current ROE % is 68.90% as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
ABH Healthcare Ltd is engaged in the business of establishing, maintaining, and assisting healthcare services in India, in the form of Super Speciality Hospitals and allied services such as Laboratories & Diagnostic Centres, Blood Bank and other related services. Its medical services cover specialties such as cardiology, neurology, gastroenterology, urology, pulmonology, nephrology, obstetrics and gynecology, critical care, orthopedics, general and laparoscopic surgery, dentistry, physiotherapy, dermatology, and radiology. The company derives the majority of inpatient revenue from its internal medicine, cardiology, neurosurgery, and orthopedics / joint replacement/trauma services.
15GF Score
Get the complete analysis for NSE:ABH
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:ABH has been successfully added to your 
